BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 38789180)

  • 21. Revitalizing Cancer Treatment: Exploring the Role of Drug Repurposing.
    Malla R; Viswanathan S; Makena S; Kapoor S; Verma D; Raju AA; Dunna M; Muniraj N
    Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Considerations and challenges for sex-aware drug repurposing.
    Fisher JL; Jones EF; Flanary VL; Williams AS; Ramsey EJ; Lasseigne BN
    Biol Sex Differ; 2022 Mar; 13(1):13. PubMed ID: 35337371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug Repositioning: A Monetary Stratagem to Discover a New Application of Drugs.
    Rohilla A; Rohilla S
    Curr Drug Discov Technol; 2024; 21(1):e101023222023. PubMed ID: 38629171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrating gene expression and clinical data to identify drug repurposing candidates for hyperlipidemia and hypertension.
    Wu P; Feng Q; Kerchberger VE; Nelson SD; Chen Q; Li B; Edwards TL; Cox NJ; Phillips EJ; Stein CM; Roden DM; Denny JC; Wei WQ
    Nat Commun; 2022 Jan; 13(1):46. PubMed ID: 35013250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repurposing drugs to treat l-DOPA-induced dyskinesia in Parkinson's disease.
    Johnston TH; Lacoste AMB; Visanji NP; Lang AE; Fox SH; Brotchie JM
    Neuropharmacology; 2019 Mar; 147():11-27. PubMed ID: 29907424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recycled Translation: Repurposing Drugs for Stroke.
    Spellicy SE; Hess DC
    Transl Stroke Res; 2022 Dec; 13(6):866-880. PubMed ID: 35218497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reimagining old drugs with new tricks: Mechanisms, strategies and notable success stories in drug repurposing for neurological diseases.
    Rani N; Kaushik A; Kardam S; Kag S; Raj VS; Ambasta RK; Kumar P
    Prog Mol Biol Transl Sci; 2024; 205():23-70. PubMed ID: 38789181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring the potential of drug repurposing for liver diseases: A comprehensive study.
    Ali FEM; Abdel-Reheim MA; Hassanein EHM; Abd El-Aziz MK; Althagafy HS; Badran KSA
    Life Sci; 2024 Jun; 347():122642. PubMed ID: 38641047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcriptomic Data Mining and Repurposing for Computational Drug Discovery.
    Wang Y; Yella J; Jegga AG
    Methods Mol Biol; 2019; 1903():73-95. PubMed ID: 30547437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects.
    Mohi-Ud-Din R; Chawla A; Sharma P; Mir PA; Potoo FH; Reiner Ž; Reiner I; Ateşşahin DA; Sharifi-Rad J; Mir RH; Calina D
    Eur J Med Res; 2023 Sep; 28(1):345. PubMed ID: 37710280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug Repurposing: A Leading Strategy for New Threats and Targets.
    Mishra AS; Vasanthan M; Malliappan SP
    ACS Pharmacol Transl Sci; 2024 Apr; 7(4):915-932. PubMed ID: 38633585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advancements in Drug Repurposing: Examples in Psychiatric Medications.
    Okuyama R
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In silico drug repositioning: what we need to know.
    Liu Z; Fang H; Reagan K; Xu X; Mendrick DL; Slikker W; Tong W
    Drug Discov Today; 2013 Feb; 18(3-4):110-5. PubMed ID: 22935104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug repurposing: far beyond new targets for old drugs.
    Oprea TI; Mestres J
    AAPS J; 2012 Dec; 14(4):759-63. PubMed ID: 22826034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug repurposing: a better approach for infectious disease drug discovery?
    Law GL; Tisoncik-Go J; Korth MJ; Katze MG
    Curr Opin Immunol; 2013 Oct; 25(5):588-92. PubMed ID: 24011665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A human-based multi-gene signature enables quantitative drug repurposing for metabolic disease.
    Timmons JA; Anighoro A; Brogan RJ; Stahl J; Wahlestedt C; Farquhar DG; Taylor-King J; Volmar CH; Kraus WE; Phillips SM
    Elife; 2022 Jan; 11():. PubMed ID: 35037854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of artificial intelligence and machine learning in drug repurposing.
    Ghandikota SK; Jegga AG
    Prog Mol Biol Transl Sci; 2024; 205():171-211. PubMed ID: 38789178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug repurposing for parasitic protozoan diseases.
    Vijayasurya ; Gupta S; Shah S; Pappachan A
    Prog Mol Biol Transl Sci; 2024; 207():23-58. PubMed ID: 38942539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An overview to drug repurposing.
    Khambhati K; Alessa AH; Singh V
    Prog Mol Biol Transl Sci; 2024; 205():1-8. PubMed ID: 38789176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Artificial intelligence in COVID-19 drug repurposing.
    Zhou Y; Wang F; Tang J; Nussinov R; Cheng F
    Lancet Digit Health; 2020 Dec; 2(12):e667-e676. PubMed ID: 32984792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.